Skip to main content
Camilo Jimenez, MD, Endocrinology, Houston, TX, University of Texas M.D. Anderson Cancer Center

CamiloJimenezMD

Endocrinology Houston, TX

Diabetes, Lipid Metabolism

Physician

Dr. Jimenez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Jimenez's full profile

Already have an account?

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2001 - 2004
  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemResidency, Internal Medicine, 1998 - 2001
  • Pontifical Xavierian University
    Pontifical Xavierian UniversityClass of 1995

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • TX State Medical License
    TX State Medical License 2007 - 2025
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Pheochromocytoma and Paraganglioma: Perioperative, Management, Surveillance, and New Imaging Modalities 
    ENDO 2019 - New Orleans, LA - 3/23/2019
  • Guided Posters: Adrenal (excluding mineralocorticoids) 
    ENDO 2019 - New Orleans, LA - 3/24/2019
  • Clinical Management of Adrenocortical Carcinoma 
    ENDO 2019 - New Orleans, LA - 3/24/2019
  • Join now to see all

Press Mentions

  • Lantheus Announces Presentation Featuring AZEDRA® (Iobenguane I 131) at ENDO 2021
    Lantheus Announces Presentation Featuring AZEDRA® (Iobenguane I 131) at ENDO 2021March 22nd, 2021
  • Cabozantinib Promising for Metastatic Pheochromocytomas, Paragangliomas
    Cabozantinib Promising for Metastatic Pheochromocytomas, ParagangliomasApril 30th, 2024
  • MD Anderson Research Highlights for April 24, 2024
    MD Anderson Research Highlights for April 24, 2024April 25th, 2024

Hospital Affiliations